MLB: Report: Mariners 2B Jorge Polanco has left knee surgery

Date:

Share post:


Seattle Mariners second baseman Jorge Polanco underwent left knee surgery on Thursday and is expected to be ready for spring training, ESPN reported.

Polanco had the patellar tendon repaired by Dr. Dan Cooper, who specializes in knee procedures and is the orthopedist for the NFL’s Dallas Cowboys, according to the report.

The 31-year-old Polanco has dealt with knee issues in recent years. This season, his first with the Mariners, the switch hitter set career lows with a .213 batting average, a .296 on-base percentage and a .651 OPS in 118 games. He had 16 home runs, 45 RBIs and a .355 slugging percentage.

Polanco, a native of the Dominican Republic, spent his first 10 seasons with the Minnesota Twins (2014-23) and was selected to the American League All-Star team as a shortstop in 2019. The Twins traded him to the Mariners on Jan. 29 for four players and cash.

He is a career .263 hitter with 128 homers, 492 RBIs, a .330 on-base percentage, a .435 slugging percentage and a .765 OPS in 950 games.

Seattle has a $12 million club option with a $750,000 buyout on Polanco’s contract, which requires a decision by early November.

–Field Level Media

spot_img

Related articles

NCAABBL: Arkansas’ Gage Wood throws 3rd no-hitter in MCWS history, eliminates Murray St.

OMAHA, Neb. -- Arkansas right-hander Gage Wood pitched just the third no-hitter in Men's College World Series history,...

NCAABBL: MCWS: Coastal Carolina upsets sloppy Oregon St. to move to 2-0

OMAHA, Neb. -- Coastal Carolina took advantage of a sloppy performance by Oregon State in coasting to a...

NCAABBL: MCWS: Louisville erupts to knock off Arizona

OMAHA, Neb. -- Zion Rose hit a go-ahead two-run bloop single down the right field line in the...

MLB: Cubs look to extend NL Central lead over Brewers

Both National League Central rivals know that mid-June is far too early to call the division, but the...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.